Key result
Experimental data suggest that K+ channel downregulation in heart failure and diabetic cardiomyopathy is driven by a redox-sensitive metabolic mechanism linked to glucose utilization.
Population
Diabetic and non-diabetic models of heart failure (e.g., diabetic rat isolated ventricular myocytes)
Design
Review
Authors
Loading...
Supports metabolic modulation as a research target in HF; hypothesis-generating from Level 5 experimental data and requires clinical validation.
Cardiac K+ channel remodelling in heart failure may be driven by a redox-sensitive mechanism linked to glucose utilization, suggesting metabolic modulation as a potential therapeutic approach.
Rozanski et al. (2002) conducted a review in Cardiovascular disease leading to heart failure and diabetic cardiomyopathy. Activators of glucose utilization (e.g., insulin, pyruvate dehydrogenase activators) was evaluated on Transient outward current (I(to)) density. Experimental data suggest that K+ channel downregulation in heart failure and diabetic cardiomyopathy is driven by a redox-sensitive metabolic mechanism linked to glucose utilization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: